Completed
Screening Study for the Evaluation and Diagnosis of Potential Research Subjects With Anterior Segment Disease
What is being collected
Data Collection
Who is being recruted
Eye Diseases
How is the trial designed
Observational
Study Start: July 2004
Summary
Principal SponsorNational Eye Institute (NEI)
Last updated: January 14, 2026
Sourced from a government-validated database.Claim as a partner
Study start date: July 13, 2004
Actual date on which the first participant was enrolled.This is a screening protocol that will allow the NEI clinicians to examine patients with ocular diseases in order to identify those who may be eligible to participate in other NEI studies on anterior segment disease.
Principal SponsorNational Eye Institute (NEI)
Last updated: January 14, 2026
Sourced from a government-validated database.Claim as a partner
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.Design Details
600 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Conditions
Criteria
Any sex
Biological sex of participants that are eligible to enroll.Healthy volunteers not allowed
If individuals who are healthy and do not have the condition being studied can participate.Conditions
Pathology
Eye Diseases
Criteria
* ELIGIBILITY CRITERIA: To participate in this screening study, a patient must have a history of anterior segment disease. Patients of all ages are eligible.
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 1 location
Suspended
National Institutes of Health Clinical Center, 9000 Rockville Pike
Bethesda, United StatesSee the locationCompletedOne Study Center